MK0683
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MK0683, covering 2009-06-01 to 2017-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008) [Phase 1]